Pharmaceutical

United Therapeutics gets grant for treatment of pulmonary hypertension using prostacyclin-treated stem cells

Discover a groundbreaking method for treating pulmonary hypertension with stem cells and prostacyclin. Learn more about this innovative patent from United Therapeutics Corp.

Apr 5, 2024 - 00:00
Discover a groundbreaking method for treating pulmonary hypertension with stem cells and prostacyclin. Learn more about this innovative patent from United Therapeutics Corp.
Read the original article

Tags:

Previous Article

Lipocine gets grant for pharmaceutical composition for treating testosterone def...

Next Article

Xencor gets grant for bispecific antibody for treating GPC3-associated cancers

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Rocket Pharmaceuticals’ RP-A601 receives FDA designations

Rocket Pharmaceuticals’ RP-A601 receives FDA designations

Jun 9, 2023

STAT+: Bristol Myers to buy cancer player Mirati for more than $4.8 billion

STAT+: Bristol Myers to buy cancer player Mirati for mo...

Oct 8, 2023

Magazine: Cell and gene therapy approvals drive paradigm change in manufacturing

Magazine: Cell and gene therapy approvals drive paradig...

Oct 10, 2024